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Objective: To evaluate the German Diabetes Risk
Score (GDRS) among the general adult German
population for prediction of incident type 2 diabetes
and detection of prevalent undiagnosed diabetes.
Methods: The longitudinal sample for prediction of
incident diagnosed type 2 diabetes included 3625
persons who participated both in the examination
survey in 1997–1999 and the examination survey in
2008–2011. Incident diagnosed type 2 diabetes was
defined as first-time physician diagnosis or antidiabetic
medication during 5 years of follow-up excluding
potential incident type 1 and gestational diabetes.
The cross-sectional sample for detection of prevalent
undiagnosed diabetes included 6048 participants
without diagnosed diabetes of the examination survey
in 2008–2011. Prevalent undiagnosed diabetes was
defined as glycated haemoglobin ≥6.5% (48 mmol/
mol). We assessed discrimination as area under the
receiver operating characteristic curve (ROC-AUC
(95% CI)) and calibration through calibration plots.
Results: In longitudinal analyses, 82 subjects with
incident diagnosed type 2 diabetes were identified after
5 years of follow-up. For prediction of incident
diagnosed diabetes, the GDRS yielded an ROC-AUC of
0.87 (0.83 to 0.90). Calibration plots indicated
excellent prediction for low diabetes risk and
overestimation for intermediate and high diabetes risk.
When considering the entire follow-up period of
11.9 years (ROC-AUC: 0.84 (0.82 to 0.86)) and
including incident undiagnosed diabetes (ROC-AUC:
0.81 (0.78 to 0.84)), discrimination decreased
somewhat. A previously simplified paper version of the
GDRS yielded a similar predictive ability (ROC-AUC: 0.86
(0.82 to 0.89)). In cross-sectional analyses, 128 subjects
with undiagnosed diabetes were identified. For detection
of prevalent undiagnosed diabetes, the ROC-AUC was
0.84 (0.81 to 0.86). Again, the simplified version yielded
a similar result (ROC-AUC: 0.83 (0.80 to 0.86)).
Conclusions: The GDRS might be applied for public
health monitoring of diabetes risk in the German adult
population. Future research needs to evaluate whether
the GDRS is useful to improve diabetes risk awareness
and prevention among the general population.
INTRODUCTION
Several diabetes risk scores have been devel-
oped in different countries, intended either
to predict risk for future type 2 diabetes or
to detect undiagnosed diabetes.1–6
Performance of a risk score is usually weaker
in external populations than in the original
population in which it was developed.2 7
Moreover, the performance of a risk score
may vary by its application in different coun-
tries.6 Therefore, risk scores should be vali-
dated within the target population prior to
their practical application.2
The German Diabetes Risk Score (GDRS)
was developed for application as an online
tool based on data of the European
Prospective Investigation into Cancer and
Nutrition (EPIC)-Potsdam for prediction of
the 5-year risk to develop type 2 diabetes.8
Further, it is recommended as a primary
screening tool for diabetes in the practice
guideline of the German Diabetes
Association.9 The original GDRS version
included information on age,
Key messages
▪ In a nationwide cohort of German adults, the
most recently updated version of the German
Diabetes Risk Score—both as a comprehensive
and simplified tool—showed an excellent dis-
crimination for 5-year risk prediction of diag-
nosed type 2 diabetes.
▪ In a nationwide cross-sectional sample represen-
tative of the German adult population, the most
recently updated version of the German Diabetes
Risk Score—both as a comprehensive and sim-
plified tool—showed an excellent discrimination
for detection of prevalent undiagnosed diabetes.
▪ The German Diabetes Risk Score might be
applied for public health monitoring of diabetes
risk in the German adult population.
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anthropometric measures, history of hypertension, and
lifestyle factors.8 It was subsequently extended by infor-
mation on family history of type 2 diabetes.10 Recently,
the GDRS was further updated to refine information on
dietary variables and smoking.11 12 In addition, a simpli-
fied paper version of the GDRS was developed.11 13
Until now, validation of the comprehensive GDRS tool
is limited to the first versions based on regional samples
from Germany or other European countries6 8 10 14–16
and validation of the simplified GDRS tool has not been
performed. Therefore, we aimed to validate the most
recently updated comprehensive GDRS—and in add-
itional analyses, also the simplified GDRS—for (1) pre-
diction of incident diagnosed type 2 diabetes in a
nationwide longitudinal sample and (2) detection of
prevalent undiagnosed diabetes in a nationwide cross-
sectional sample representative of the German popula-
tion aged 18–79 years.
RESEARCH DESIGN AND METHODS
Health interview and examination surveys
The ‘German National Health Interview and
Examination Survey 1998’ (GNHIES98; 1997–1999) com-
prises a representative sample of the non-institutionalized
population in Germany aged 18–79 years.17 For the
‘German Health Interview and Examination Survey for
Adults’ (DEGS1; 2008–2011), eligible participants of
GNHIES98 were invited to re-participate (response:
62%). To retain a representative cross-sectional sample of
the non-institutionalized population in Germany aged
18–79 years, this sample was extended by a sample of first-
time invitees (response: 42%).17 18 Both surveys were
approved by the Federal Commissioner for Data
Protection and DEGS1 was approved by the Ethics
Committee of the Charité-Universitätsmedizin Berlin
(number EA2/047/08). All participants provided written
informed consent.18
Study population
Figure 1 depicts the overall flow chart of the study popu-
lation. In the longitudinal analysis, persons who partici-
pated in GNHIES98 (baseline) and DEGS1 (follow-up,
n=3959) were considered. Exclusion criteria are shown
in figure 1. The final ‘GNHIES98—longitudinal sample’
for validating the GDRS for prediction of incident diag-
nosed type 2 diabetes included 3625 subjects.
In the cross-sectional analysis, DEGS1 participants
aged 18–79 years who completed the examination part
(n=7115) were considered. Exclusion criteria are dis-
played in figure 1. The final ‘DEGS1—cross-sectional
sample’ for validating the GDRS for detection of preva-
lent undiagnosed diabetes included 6048 subjects.
Ascertainment of diabetes status
Incident diagnosed type 2 diabetes was defined as phys-
ician diagnosis of diabetes or intake of antidiabetic
medication reported for the first time at follow-up.
Incident cases of type 1 or gestational diabetes were
excluded as previously described.19 Since the GDRS was
developed for prediction of the 5-year diabetes risk, we
only considered those who developed type 2 diabetes
within the first 5 years of follow-up as incident cases in
the main analyses.
Prevalent undiagnosed diabetes was defined according
to the glycated haemoglobin (HbA1c)-diagnostic criterion
recommended by the American Diabetes Association.20
HbA1c was measured in previously thawed whole blood
with an immunoturbidimetric method using the
Architect ci8200 device (Abbott, Wiesbaden,
Germany).21 We relied solely on HbA1c as a diagnostic
criterion in the main analyses since fasting glucose was
only obtained in a non-random subsample. However, in
a sensitivity analysis, we additionally considered glucose
values by using different cut-offs for the fasting and the
non-fasting subsamples.9
Assessment of GDRS components
The GDRS includes the following components: age,
waist circumference, height, history of hypertension,
physical activity, smoking, family history of diabetes,
intake of red meat, wholegrain and muesli, and coffee
consumption.11 While the comprehensive GDRS version
considers continuous risk factor units where applicable,
the simplified version exclusively considers categorized
units.11
In GNHIES98 and DEGS1, these components were
measured as follows. Information on smoking and sport
activity was assessed by standardized self-administered
questionnaires. Smoking status was assessed as never,
daily, occasional, or former smoking including the
number of cigarettes smoked per day. For calculation of
GDRS points in the current study, daily smoking and
occasional smoking were aggregated into current
smoking. Regular sport activity was assessed by five cat-
egories (‘no sport’, ‘<1 hour/week’, ‘1–2 hours/week’,
‘2–4 hours/week’, ‘>4 hours/week’). For calculation of
GDRS points in this study, the mean time of each cat-
egory was assigned to create a quasi-continuous variable
(0, 0.5, 1.5, 3.0, 4.5 hours/week).
Standardized physician administered interviews were
used to assess physician-diagnosed hypertension in
surveys and parental history of diabetes in DEGS1. To
preclude exclusion of participants with missing informa-
tion on parental history of diabetes in this study, we
assigned the prevalence of a history of diabetes among
participants with available information to those with
missing information as a constant. This constant was cal-
culated before application of further exclusion criteria.
Information on a sibling history of diabetes was not
assessed in GNHIES98 or DEGS1. Thus, we assigned the
prevalence of a sibling history of diabetes observed in
EPIC-Potsdam (5.0%) as a constant to all participants.10
Body height and waist circumference were assessed by
standardized measurements to the nearest 0.1 cm per-
formed by trained health professionals.
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In GNHIES98, dietary intake was assessed through a
food frequency questionnaire (FFQ) with seven categories
(from ‘(almost) never’ to ‘several times/day’).
Additionally, in a subset of 4030 GNHIES98 participants
who participated in the Nutrition Survey module, a dietary
history interview was conducted assessing usual frequen-
cies and amounts consumed during the past 4 weeks.22 23
In this subset, the mean amount consumed per day of
each respective item was calculated for each category of
frequency as used for the GNHIES98-FFQ and stratified
according to sex and age group (18–39, 40–59, ≥60 years).
The obtained values were allocated to the respective cat-
egories of frequency for all GNHIES98 participants. To
account for differences in food grouping between the
GNHIES98-FFQ and the use as in the GDRS, namely
‘coffee with caffeine’ versus ‘coffee’, ‘meat (including
poultry)’ versus ‘red meat’ and ‘muesli, cornflakes, and
oatmeal’ versus ‘muesli’, only compatible information
from the Nutrition Survey module was used to calculate
daily amounts, which were then allocated to the aforemen-
tioned FFQ categories for all GNHIES98 participants.
In DEGS1, a semiquantitative FFQ was applied with 11
categories of frequency (from ‘never’ to ‘>5 times/day’)
and 5 categories of amounts (from ‘≤0.5 cup’ to ‘≥4
cups’ for coffee, ‘≤0.5 slice or roll’ to ‘≥4 slices or rolls’
for wholegrain bread/rolls, ‘≤0.25 bowl’ to ‘≥3 bowls’
for muesli, and ‘0.25 portion’ to ‘≥3 portions’ for red
meat). Since categories of amount were comparable in
DEGS1 and EPIC-Potsdam, calculation of the average
intake in grams per day was based on standard portion
sizes from EPIC-Potsdam (ie, 150 g for red meat, 150 mL
for coffee, 50 g for wholegrain bread and muesli).
Statistical analysis
Points of the recently updated comprehensive
GDRS version were calculated by the following formula:11
5.1×age (years)+7.6×waist circumference (cm)—
2.7×height (cm)+47×history of hypertension—2×physical
activity (hours/week)+15×former smoking (<20 cigar-
ettes/day)+45×former smoking (≥20 cigarettes/day)
+23×current smoking (<20 cigarettes/day)+77×current
smoking (≥20 cigarettes/day)+55×red meat (portions
(150 g)/day)—7×wholegrain bread and muesli (por-
tions (50 g)/day)—5×coffee (cups (150 mL)/day)
+56×one parent with diabetes+106×both parents with
diabetes+48×at least one sibling with diabetes.
Figure 1 Participant flow diagram for the ‘GNHIES98—longitudinal sample’ and the ‘DEGS1—cross-sectional sample’. DEGS1,
German Health Interview and Examination Survey for Adults; GDRS, German Diabetes Risk Score; GNHIES98, German
National Health Interview and Examination Survey 1998; HbA1c, glycated haemoglobin.
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On the basis of calculated GDRS points for each individ-
ual, predicted 5-year diabetes risk was determined
(P5 years=1–0.99061
exp((GDRS points—474.17096591)/100)). The
comprehensive GDRS is available as an online tool with
an automatic calculation of predicted diabetes risk after
entry of individual risk factor values.12
For validation of the GDRS, we assessed discrimination
by logistic regression as area under the receiver operating
characteristic curve (ROC-AUC). According to previous
suggestions, an ROC-AUC of 0.7–0.8 was rated as acceptable
and of >0.8 as excellent.24 The 95% CI was estimated via a
bootstrap procedure with 2000 replicates by resampling the
sample points25 and using the 2.5% and 97.5% percentiles
of the bootstrapped distribution as CI. In addition, for pre-
diction of incident type 2 diabetes, we evaluated calibration
with a calibration plot comparing the observed risk, that is,
the proportion of observed incident cases in each of the
predefined groups, with the predicted risk, that is, the geo-
metric mean of predicted risk in each of the respective
groups.26 Owing to the relatively low number of persons
with incident type 2 diabetes within 5 years of follow-up, we
defined quintiles based on predicted diabetes risk instead
of the commonly applied deciles. Besides, we calculated
sensitivity, specificity, positive and negative predictive value
(PPV and NPV) using the same cut-offs of predicted dia-
betes risk as in previous analyses.10
Further, we performed several sensitivity analyses
(figure 1). For longitudinal sensitivity analyses, first,
the study population was confined to participants aged
35–65 years according to the age range of EPIC-Potsdam.
Second, information on incident diagnosed type 2 dia-
betes within the entire follow-up period was considered.
Third, persons with incident HbA1c-defined undiag-
nosed diabetes (HbA1c≥6.5% (≥48 mmol/mol))20 were
additionally included as cases. Fourth, persons
with incident glucose-defined undiagnosed diabetes
(fasting glucose ≥7.0 mmol/L or non-fasting glucose
≥11.0 mmol/L)9 were additionally included as cases.
For cross-sectional sensitivity analyses, first, the study
population was confined to participants aged 35–65 years.
Second, persons with glucose-defined undiagnosed dia-
betes were additionally considered to the HbA1c-defined
cases (based on the criteria described above). Moreover,
we investigated the score’s performance for detection of
prevalent pre-diabetes (defined as HbA1c 5.7–6.4% (39–
47 mmol/mol),20 n=1426) after exclusion of participants
with prevalent undiagnosed diabetes from the ‘DEGS1—
cross-sectional sample’ (n=5920).
In the longitudinal and cross-sectional analyses, we add-
itionally validated the most recently updated simplified
paper version of the GDRS. For the simplified GDRS, risk
factors were assessed in categories with points allocated to
each category. Based on the sum of these points for each
individual, predicted 5-year diabetes risk was calculated
(P5 years=1–0.99061
exp((simplified GDRS points—38.4558938)/10)).11
When using the paper version, predicted risk is easily deriv-
able by assigning determined GDRS points to a graphically
presented scale.27
Analyses were performed with SAS V.9.4 (SAS
Institute, Cary, North Carolina, USA) using complex
survey procedures and including weighting factors as
described in detail previously.28 To determine whether
exclusion of subjects with missing data had influence on
the findings of this study, multiple imputation of missing
data in GDRS components was applied using the fully
conditional specification method.29 In total, 10 complete
data sets were imputed. In the longitudinal and cross-
sectional analyses, results only marginally changed when
multiple imputation was applied (data not shown).
RESULTS
Prediction of incident diagnosed type 2 diabetes
During 5 years of follow-up, 82 of the 3625 partici-
pants in the ‘GNHIES98—longitudinal sample’
reported a new diagnosis of type 2 diabetes. Incident
cases on average were older and shorter, had a higher
waist circumference, a lower sport activity and whole-
grain intake, were less likely current smokers of <20
cigarettes per day and more likely to have a history of
hypertension and parental history of diabetes than
those without incident diabetes (table 1). Accordingly,
GDRS points (714.3 vs 488.2 points) and the corre-
sponding predicted 5-year diabetes risk (9.6% vs
1.1%) were considerably higher among participants
with incident diabetes compared with those without
incident diabetes.
For prediction of incident diagnosed type 2 diabetes,
the GDRS yielded an ROC-AUC of 0.87 (0.83 to 0.90).
The calibration plot (figure 2) indicated that in the
lowest risk group predicted risk perfectly agreed with
observed risk (predicted risk/observed risk: 0.1%/
0.1%). However, predicted risk was overestimated in the
remaining groups (second group: 0.4%/0.2%; third
group: 1.1%/0.1%; fourth group: 2.9%/2.2%; fifth
group: 11.0%/8.1%). Sensitivity, specificity, PPV and
NPV for selected cut-offs of predicted 5-year diabetes
risk are shown in table 2. The cut-off with a maximum
in the sum of sensitivity and specificity was at 3.1% of
predicted risk (sensitivity: 0.95, specificity: 0.73, PPV:
0.07, NPV: 1.00).
In sensitivity analyses, we observed similar results
(ROC-AUC: 0.86 (0.82 to 0.89)) when restricting the
sample to 35–65-year-olds. Considering those with inci-
dent diagnosed diabetes within the entire follow-up
period of 11.9 years as cases resulted in a slightly
decreased ROC-AUC (0.84 (0.82 to 0.86)). Additional
consideration of persons with incident undiagnosed dia-
betes as cases led to a further slight decrease in discrimin-
ation (ROC-AUC: HbA1c-based: 0.81 (0.78 to 0.84);
HbA1c-based and glucose-based: 0.81 (0.78 to 0.84)).
The simplified GDRS version showed a similar dis-
crimination (ROC-AUC: 0.86 (0.82 to 0.89)) as com-
pared with the comprehensive version and only
marginal changes in the calibration plot (see online
supplementary figure S1).
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Detection of prevalent undiagnosed diabetes
In the ‘DEGS1—cross-sectional sample’, 128 cases of
HbA1c-defined undiagnosed diabetes out of 6048
participants were identified. Participants with undiag-
nosed diabetes on average were older, had a higher waist
circumference, a lower sport activity and were more
likely to have a history of hypertension and parental
history of diabetes compared with those without
undiagnosed diabetes (table 3). Additionally, they were
less likely to be former or current smokers of <20 cigar-
ettes per day, but more likely to be former or current
smokers of ≥20 cigarettes per day. Consequently, GDRS
points (736.6 vs 485.9 points) and the corresponding
predicted 5-year diabetes risk (11.3% vs 1.0%) were sig-
nificantly higher among participants with undiagnosed
diabetes compared with those without undiagnosed
diabetes.
For detection of prevalent undiagnosed diabetes, the
GDRS showed an ROC-AUC of 0.84 (0.81 to 0.86).
Sensitivity, specificity, PPV and NPV for selected cut-offs
of predicted 5-year diabetes risk are shown in table 2.
In sensitivity analyses, when limiting the sample to
35–65-year-olds (ROC-AUC: 0.83 (0.79 to 0.88)) or
defining undiagnosed diabetes by combining HbA1c
with glucose criteria (ROC-AUC: 0.84 (0.82 to 0.86)),
results for discrimination only marginally changed.
The simplified GDRS version showed a similar discrim-
ination (ROC-AUC: 0.83 (0.80 to 0.86)) as compared
with the comprehensive version.





diagnosed type 2 diabetes
(n=82)
Participants without incident
diagnosed type 2 diabetes
(n=3543)
Age (years) 55.0 (51.5 to 58.6) 42.4 (41.6 to 43.2) <0.01
Height (cm) 166.5 (163.6 to 169.4) 170.1 (169.6 to 170.5) 0.02
Waist circumference (cm) 103.5 (100.1 to 106.9) 88.7 (88.0 to 89.3) <0.01
Hypertension (%) 50.5 (37.3 to 63.7) 17.5 (15.7 to 19.4) <0.01
Sport activity (hours/day) 0.6 (0.3 to 0.8) 1.1 (1.1 to 1.2) <0.01
Former smoker of <20 cigarettes/day (%) 11.3 (5.6 to 21.3) 11.3 (10.1 to 12.5) 1.00
Former smoker of ≥20 cigarettes/day (%) 11.9 (5.4 to 24.5) 9.1 (8.1 to 10.3) 0.51
Current smoker of <20 cigarettes/day (%) 11.7 (6.4 to 20.2) 20.6 (18.5 to 22.8) 0.03
Current smoker of ≥20 cigarettes/day (%) 17.6 (9.5 to 30.3) 14.1 (12.5 to 15.9) 0.48
Wholegrain intake (each 50 g/day) 1.0 (0.8 to 1.2) 1.3 (1.3 to 1.4) <0.01
Coffee consumption (each 150 g/day) 2.8 (2.5 to 3.1) 2.7 (2.6 to 2.8) 0.66
Red meat intake (each 150 g/day) 0.6 (0.5 to 0.6) 0.6 (0.6 to 0.6) 0.81
One parent with diabetes (%)* 49.7 (34.3 to 65.2) 26.8 (24.8 to 28.9) <0.01
Both parents with diabetes (%)* 10.6 (5.3 to 20.0) 1.6 (1.1 to 2.1) <0.01
One or more siblings with diabetes (%)† 5.0 5.0 –
GDRS (points) 714.3 (692.1 to 736.4) 488.2 (480.2 to 496.2) <0.01
Predicted 5-year diabetes risk (%) 9.6 (7.8 to 11.8) 1.1 (1.0 to 1.2) <0.01
Values are given as weighted percentage (95% CI), weighted arithmetic mean (95% CI) or, in case of predicted 5-year diabetes risk, as
weighted geometric mean (95% CI). Differences in proportions and means between groups were assessed by χ² test or ANOVA.
*Information was used as reported at follow-up (DEGS1). Missing information (n=20 with incident diabetes, n=467 without incident diabetes) is
replaced by a constant reflecting the prevalence of parental history of diabetes among participants with available information.
†Information was not available and is substituted by a constant reflecting the prevalence of a sibling history of diabetes in EPIC-Potsdam.
ANOVA, analysis of variance; DEGS1, German Health Interview and Examination Survey for Adults; EPIC, European Prospective Investigation
into Cancer and Nutrition; GDRS, German Diabetes Risk Score; GNHIES98, German National Health Interview and Examination Survey 1998.
Figure 2 Calibration plot by quintiles of predicted 5-year
diabetes risk of the comprehensive German Diabetes Risk
Score (GDRS) for prediction of incident diagnosed type 2
diabetes in the ‘German National Health Interview and
Examination Survey 1998 (GNHIES98)—longitudinal sample’
(N=3625).
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For detection of prevalent pre-diabetes, the GDRS
showed an ROC-AUC of 0.71 (0.69 to 0.74).
DISCUSSION
On the basis of a nationwide longitudinal sample of the
German adult population, validation of the GDRS for
5-year risk prediction of diagnosed type 2 diabetes
revealed excellent discrimination as well as perfect pre-
diction for low diabetes risk and slight-to-moderate over-
estimation for intermediate to high risk. The simplified
GDRS version yielded a similar predictive ability.
Considering the entire follow-up period of about
12 years and including undiagnosed diabetes for defin-
ing incident cases diminished performance somewhat.
Furthermore, in a nationwide cross-sectional sample
Table 2 Sensitivity, specificity, PPV and NPV of the GDRS according to selected cut-offs of predicted 5-year diabetes risk in
the ‘GNHIES98—longitudinal sample’ (N=3625) and the ‘DEGS1—cross-sectional sample’ (N=6048)
Predicted 5-year
diabetes risk (%) GDRS points* (≈)
GNHIES98—longitudinal sample DEGS1—cross-sectional sample
Prediction of incident diagnosed type
2 diabetes
Detection of prevalent undiagnosed
diabetes
Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV
1.0 480 0.97 0.49 0.04 1.00 0.95 0.50 0.04 1.00
2.0 550 0.96 0.64 0.06 1.00 0.91 0.63 0.05 1.00
2.5 572 0.96 0.69 0.06 1.00 0.89 0.67 0.05 1.00
3.0 590 0.95 0.72 0.07 1.00 0.88 0.70 0.06 1.00
4.0 619 0.84 0.78 0.08 1.00 0.81 0.75 0.07 0.99
5.0 641 0.75 0.81 0.08 0.99 0.78 0.79 0.07 0.99
10.0 711 0.51 0.91 0.12 0.99 0.61 0.89 0.11 0.99
15.0 751 0.27 0.95 0.10 0.98 0.44 0.93 0.13 0.99
20.0 780 0.20 0.97 0.12 0.98 0.36 0.96 0.14 0.99
*In the ‘GNHIES98—longitudinal sample’, GDRS points ranged from 115.4 to 1000.5 points. In the ‘DEGS1—cross-sectional sample’, GDRS
points ranged from 77.3 to 1128.2 points.
DEGS1, German Health Interview and Examination Survey for Adults; GDRS, German Diabetes Risk Score; GNHIES98, German National
Health Interview and Examination Survey 1998; NPV, negative predictive value; PPV, positive predictive value.









Age (years) 58.6 (55.7 to 61.5) 45.8 (45.3 to 46.3) <0.01
Height (cm) 171.6 (169.5 to 173.8) 170.7 (170.3 to 171.1) 0.41
Waist circumference (cm) 108.0 (104.9 to 111.1) 88.7 (88.1 to 89.3) <0.01
Hypertension (%) 65.9 (54.8 to 75.5) 29.8 (28.5 to 31.2) <0.01
Sport activity (hours/day) 1.0 (0.7 to 1.3) 1.4 (1.4 to 1.5) <0.01
Former smoker of <20 cigarettes/day (%) 9.9 (5.5 to 17.1) 17.7 (16.4 to 19.1) 0.03
Former smoker of ≥20 cigarettes/day (%) 25.5 (15.7 to 38.5) 10.1 (9.2 to 11.1) <0.01
Current smoker of <20 cigarettes/day (%) 12.4 (7.2 to 20.7) 22.2 (20.8 to 23.7) 0.02
Current smoker of ≥20 cigarettes/day (%) 14.2 (8.4 to 23.2) 7.9 (6.9 to 9.0) 0.03
Wholegrain intake (each 50 g/day) 1.3 (0.9 to 1.7) 1.2 (1.2 to 1.3) 0.59
Coffee consumption (each 150 g/day) 3.1 (2.5 to 3.6) 3.3 (3.1 to 3.4) 0.46
Red meat intake (each 150 g/day) 0.4 (0.3 to 0.4) 0.3 (0.3 to 0.3) 0.18
One parent with diabetes (%)* 39.8 (28.1 to 52.8) 22.2 (20.7 to 23.7) <0.01
Both parents with diabetes (%)* 5.5 (2.3 to 12.5) 1.7 (1.3 to 2.2) <0.01
One or more siblings with diabetes (%)† 5.0 5.0 –
GDRS (points) 736.6 (705.5 to 767.7) 485.9 (479.0 to 492.8) <0.01
Predicted 5-year diabetes risk (%) 11.3 (8.6 to 14.9) 1.0 (1.0 to 1.1) <0.01
Values are given as weighted percentage (95% CI), weighted arithmetic mean (95% CI) or, in case of predicted 5-year diabetes risk, as
weighted geometric mean (95% CI). Differences in proportions and means between groups were assessed by χ² test or ANOVA.
*Missing information (n=13 with undiagnosed diabetes, n=367 without undiagnosed diabetes) is replaced by a constant reflecting the
prevalence of parental history of diabetes among participants with available information.
†Information was not available and is substituted by a constant reflecting the prevalence of a sibling history of diabetes in EPIC-Potsdam.
ANOVA, analysis of variance; DEGS1, German Health Interview and Examination Survey for Adults; EPIC, European Prospective
Investigation into Cancer and Nutrition; GDRS, German Diabetes Risk Score.
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representative of the German adult population, the
GDRS showed excellent discrimination for detection of
prevalent undiagnosed diabetes for both its comprehen-
sive and simplified versions.
Prediction of incident diagnosed type 2 diabetes
Previous versions of the comprehensive GDRS have
been validated for prediction of type 2 diabetes risk in
several regional German studies, indicating good exter-
nal performance overall.8 10 14 In this study, covering a
wide age range (18–79 years), the discrimination of the
most recently updated GDRS (ROC-AUC: 0.87 (0.83 to
0.90)) was similar to its performance in EPIC-Potsdam,
in which the score was derived (age range 35–65 years;
ROC-AUC: 0.86 (0.84 to 0.87)).11 Furthermore, discrim-
ination was comparable to the performance of a slightly
different previous GDRS version (including alcohol con-
sumption but less-extensive information on wholegrain
intake and smoking) in a regional study from southern
Germany (age range 25–74 years; ROC-AUC: 0.84 (0.82
to 0.86)).10 The relatively high ROC-AUC of the GDRS
in this study may be explained by a larger heterogeneity
in our study population compared with the EPIC-
Potsdam population, for example, due to a broader age
range and the nationwide sampling.16 30 In line with
expectations, restricting our study population to the
EPIC-Potsdam age range slightly decreased the
ROC-AUC. Additional analysis showed that considering
the entire follow-up period for defining incident cases
slightly decreased discrimination. This tendency was also
seen in other studies when considering a longer
follow-up time than in the original model.6 16 Inclusion
of undiagnosed diabetes for defining incident cases
further decreased discrimination. This is in accordance
with the finding of another validation study within a
regional German cohort study of older adults14 and may
be explained by the fact that the GDRS was specifically
developed to predict the 5-year diabetes risk of diag-
nosed, that is, a rather manifest, diabetes.8
For the lower risk groups, the calibration plot in
EPIC-Potsdam was comparable to the one in our study.10
However, while diabetes risk was slightly underestimated
in the highest risk group in EPIC-Potsdam, it was overesti-
mated in this study. The latter observation is in accord-
ance with findings from the above mentioned regional
study from southern Germany.10 Also, in an external val-
idation study of several diabetes risk scores, it was found
that even after recalibration most diabetes risk scores
overestimate actual diabetes risk.16 Similarly, recalibra-
tion6 did not substantially improve calibration of the
GDRS in this study (data not shown). However, as a pre-
diction tool, a diabetes risk score should correctly identify
persons at increased diabetes risk to initiate further
testing or preventive actions in the appropriate target
group. Consequently, an overestimated risk among those
who are already in the high-risk group is less important
for decisions in clinical practice as opposed to an overesti-
mated risk in those with a low diabetes risk, which could
lead to unnecessary further testing.6 10 16 31 Therefore,
the overestimated risk in the higher risk groups may not
necessarily preclude a correct identification of those with
a high diabetes risk.16
Until now, this is the first study to validate the simpli-
fied GDRS version. The results on discrimination and
calibration were comparable to those of the comprehen-
sive GDRS version in this study and by that being com-
parable to the findings in EPIC-Potsdam.11
Detection of prevalent undiagnosed diabetes
For detection of undiagnosed diabetes, only the original
GDRS version has been validated in two regional
German studies yielding an acceptable to excellent dis-
crimination (ROC-AUC: 0.75 and 0.83) with undiag-
nosed diabetes being defined by 2-hour postchallenge
glucose.8 Until now, this is the first study to assess the
GDRS for detection of prevalent undiagnosed diabetes
in the target population by using a representative
sample of the German adult population. The finding of
an excellent discrimination (ROC-AUC: 0.84 (0.81 to
0.86)) remained nearly unchanged when including
glucose-based criteria additionally to the HbA1c criter-
ion for the definition of undiagnosed diabetes or by
relying on the simplified GDRS version.
With regard to pre-diabetes, a previous analysis in a
subsample of EPIC-Potsdam also suggested its suitability
for identification of persons with impaired fasting
glucose (ROC-AUC: 0.79).15 However, results of our
study (ROC-AUC: 0.71 (0.69 to 0.74)) only limitedly
suggest its application for detection of HbA1c-defined
pre-diabetes.
Applicability of the GDRS
In their practice guideline, the German Diabetes
Association recommends the GDRS as a primary screen-
ing tool for diabetes.9 The findings of this study provide
some evidence that is in support of the GDRS as a suit-
able primary screening tool for undiagnosed diabetes
among the German adult population beside its original
assignment as a prediction tool.
Several international guidelines recommend a stepwise
approach to identify persons at high risk for or with yet
undiagnosed type 2 diabetes among the general adult
population, that is, the application of a validated risk score
followed by a blood test in those with an increased
score.32–35 As part of this approach, for example, the
FINnish Diabetes RIsk SCore (FINDRISC)36 is suggested
by some international guidelines33–35 and the Leicester
Risk Assessment score is suggested by the National
Institute for Health and Care Excellence for the multi-
ethnic setting in England.32 37 Both scores are
self-assessment tools and comparable to the GDRS in their
main components.36 37
Since it is recommended to preferably implement a
diabetes risk score as part of a screening approach that
was developed and validated in the target population,2 38
we evaluated the GDRS among the German adult
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population showing a convincing performance for pre-
diction of diabetes risk and detection of prevalent
undiagnosed diabetes. Further, it has been proposed
that a risk score should be based on non-invasive tests
and should consist of a limited number of components
to ensure its usability.1 16 The GDRS, indeed, exclusively
relies on non-invasively measured risk factors. However,
for the comprehensive online tool,12 information on a
relatively large number of risk factors is required and
complex background formulas for calculation of GDRS
points and predicted risk are used. Therefore, a simpli-
fied paper version of the GDRS has been developed
with risk factors summarized to 10 items and a simplified
calculation procedure.11 13 A validation of this simplified
version in this study led to similar results as for the com-
prehensive version. However, the extent to which the
application of the GDRS might help to increase diabetes
risk awareness among the general population and the
effectiveness of preventive measures still needs to be
evaluated in future studies.1 7 39
Limitations
Limitations of this study include that information on a
sibling history of diabetes was not available. Therefore,
according to the approach of a former validation
study,10 prevalence of a positive sibling history of dia-
betes from EPIC-Potsdam was applied instead.
Additionally, in the ‘GNHIES98—longitudinal sample’
and the ‘DEGS1—cross-sectional sample’, there was a
considerable proportion of participants with missing
information on parental history of diabetes (13% and
6%). Thus, we applied the prevalence of a positive par-
ental history of diabetes among participants with avail-
able information to those with missing information,
again following the approach of a previous validation
study.10 This might have decreased the variance in the
family history of diabetes variables and may have led to
an underestimation in the score’s performance.10
Further, there were differences in the assessment of
some GDRS components between EPIC-Potsdam and
our surveys. In EPIC-Potsdam, physical activity included
sports, biking and gardening, whereas in our surveys
only regular sport activity was assessed. Furthermore, in
GNHIES98, only frequencies but not amounts of dietary
intake were assessed and some food categories differed
from those assessed in EPIC-Potsdam. However, we used
detailed food consumption data from the Nutrition
Survey module to assign appropriate values for the
respective GDRS food groups as accurately as possible.
In the ‘GNHIES98—longitudinal sample’, the defin-
ition of incident diabetes largely relied on a self-
reported diagnosis without verification through partici-
pants’ medical records. In addition, cases of yet undiag-
nosed diabetes might have been present at baseline or
follow-up and led to an overestimation or underestima-
tion in ROC-AUC and observed risk.16 However, we
addressed this issue by a sensitivity analysis as discussed
above.
Finally, we previously showed that participants of
GNHIES98 who re-participated in DEGS1 differed in some
characteristics from those who were alive but did not
re-participate or from those who were deceased.19
Therefore, despite the application of complex weighting
factors to also account for the incomplete follow-up of
GNHIES98 participants, a selection bias has to be consid-
ered for interpretation of results from longitudinal analyses.
Conclusion
Our findings, based on a nationwide cohort of German
adults, suggest that the GDRS is a suitable tool for pre-
diction of future type 2 diabetes risk and might hence
be applied for public health monitoring of diabetes risk
in Germany. Further, our results from a nationwide
cross-sectional study also reflect a reasonable perform-
ance of the GDRS for detection of prevalent undiag-
nosed diabetes. Additional research is needed to
evaluate the benefit of the GDRS in terms of diabetes
risk awareness and effectiveness of prevention.
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